ADXS Financials
Ayala Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.25
Market Cap
$1.71M
EPS
$-7.99
Income Statement Highlights
Most Recent Quarter: 2023-12-31
Revenue
$13000.00
Gross Profit
$0.00
Operating Income
$-36.27M
Net Income
$-48.07M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$16.58M
Total Liabilities
$41.00M
Shareholders Equity
$-24.42M
Cash & Equivalents
$4.88M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-29.48M
CapEx
$0
Free Cash Flow
$-29.48M
Profitability Metrics
Operating Margin
-2712.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ADXS revenue?
ADXS's most recent quarterly revenue was $13000.00. Annual revenue can be calculated by summing the four most recent quarters.
Is ADXS profitable?
ADXS reported a loss of $48.07M in the most recent quarter.
What is ADXS market cap?
ADXS has a market capitalization of $1.71M, making it a small-cap stock.
Does ADXS have debt?
View ADXS's balance sheet for debt information.
What is ADXS cash flow?
ADXS's most recent quarterly free cash flow was $-29.48M.